學門類別
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- A practical guide to SEC ï¬nancial reporting and disclosures for successful regulatory crowdfunding
- Quality shareholders versus transient investors: The alarming case of product recalls
- The Health Equity Accelerator at Boston Medical Center
- Monosha Biotech: Growth Challenges of a Social Enterprise Brand
- Assessing the Value of Unifying and De-duplicating Customer Data, Spreadsheet Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise, Data Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise
- Board Director Dilemmas: The Tradeoffs of Board Selection
- Barbie: Reviving a Cultural Icon at Mattel (Abridged)
- Happiness Capital: A Hundred-Year-Old Family Business's Quest to Create Happiness
AccelleWell: Surviving a Toxic CEO
內容大綱
By September 2022, Elizabeth Hooper had been working for 100 days as chief human resources officer at AccelleWell, a contract development and manufacturing organization in Cambridge, Massachusetts. Just before her arrival, AccelleWell was acquired by the private equity firm Evenhuis Equity Partners. The company's chief executive officer who hired Hooper was fired shortly after she started and was replaced by a new "fixer" who was brought in to turn around the company. Initially, Hooper thought that she could work well with the new leader, who voiced his support for Hooper publicly at an all-staff meeting and approved her plan to add new positions to the human resources team. However, he soon proved to be a toxic leader, making sexist and ageist comments and firing various executive team members. Hooper wondered if she could hold on to her own job. Was there any hope that she could still be successful as part of the executive team that had transformed AccelleWell into a leading life sciences employer?